Global Screening for Liver Cancer Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Screening for Liver Cancer Market 2023 by Company, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Screening for Liver Cancer market size was valued at USD 8969.4 million in 2022 and is forecast to a readjusted size of USD 14300 million by 2029 with a CAGR of 6.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Globally, liver cancer is one of the leading causes of cancer-related deaths. According to the American Cancer Society, the incidence of liver cancer has tripled since the 1980s, and the death rate has now doubled. In the United States, about 41,260 new cases are expected to be diagnosed, while about 30,520 deaths from liver cancer are expected, according to 2022 cancer statistics. The global prevalence of liver cancer and the continuous exposure of related populations to risk factors will rapidly drive the screening and diagnostics market.

Screening for Liver Cancer

This report is a detailed and comprehensive analysis for global Screening for Liver Cancer market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Screening for Liver Cancer market size and forecasts, in consumption value ($ Million), 2018-2029

Global Screening for Liver Cancer market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Screening for Liver Cancer market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Screening for Liver Cancer market shares of main players, in revenue ($ Million), 2018-2023.

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Screening for Liver Cancer

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace.

This report profiles key players in the global Screening for Liver Cancer market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Inc., Berry Oncology, New Horizon Health and BGI, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Screening for Liver Cancer market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Hematology Test
Imaging Test

Market segment by Application
Hospital
Clinic
Other

Market segment by players, this report covers
Abbott Laboratories
Thermo Fisher Scientific, Inc.
Berry Oncology
New Horizon Health
BGI
GTH.O
Livzon
BNR.O
SingLera
Fujifilm Medical Systems U.S.A., Inc.
F. Hoffmann-La Roche Ltd.
Siemens Healthineers
BD
Illumina, Inc.
Epigenomics AG

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Screening for Liver Cancer product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Screening for Liver Cancer, with revenue, gross margin and global market share of Screening for Liver Cancer from 2018 to 2023.

Chapter 3, the Screening for Liver Cancer competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Screening for Liver Cancer market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Screening for Liver Cancer.

Chapter 13, to describe Screening for Liver Cancer research findings and conclusion.